Management of patients taking antiplatelet or anticoagulant medication requiring invasive breast procedures: United Kingdom survey of radiologists' and surgeons' current practice.
OBJECTIVE
To determine the current practice in the UK National Health Service Breast Screening Programme for invasive diagnostic procedures and surgery in patients taking anticoagulant and antiplatelet medication.


METHODS
Lead radiologists and surgeons at each breast screening service were surveyed to determine current practice. One hundred and five respondents provided information regarding their services, protocols, and willingness to proceed with combinations of procedures and anti-haemostatic medications.


RESULTS
Between units there was wide variation in practice. Within 21 services providing more than one response, 10 (48%) disagreed on whether protocols existed. Decisions to perform biopsies were unrelated to professional group. The taking of a drug history was variable. Surgeons reported more adverse effects than radiologists [21 (48%) versus 12 (26%)], but no difference in self-assessment of knowledge.


CONCLUSIONS
Both radiologists and surgeons have expressed uncertainty about their understanding of anticoagulant and antiplatelet treatment. This is reflected in a wide range of practice. Guidance regarding the management of these patients is suggested.
Pritchard
M G
MG
West Midlands Breast Screening Quality Assurance Reference Centre, West Midlands Cancer Intelligence Unit, University of Birmingham, and University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham, UK.
Townend
J N
JN
Lester
W A
WA
England
D W
DW
Kearins
O
O
Bradley
S A
SA
D000925:Anticoagulants / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D001706:Biopsy; D001940:Breast / Q000473:pathology / Q000601:surgery; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D015642:Radiology, Interventional; D018570:Risk Assessment; D013222:State Medicine; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D006113:United Kingdom
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors